CHRN stock news · ChronoScale Holdings Corp
Get alerts for CHRN
Follow ChronoScale Holdings Corp (CHRN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CHRNChronoScale Holdings Corp shared details about a private stock sale and an investor presentation.
NeutralChronoScale filed an amended report adding an investor presentation shared with prospective investors in its stock placement. The report gives no placement terms or business results, so this filing alone does not change the company's outlook.
ChronoScale Holdings Corp will sell stock in two deals that could bring in up to $500 million.
NeutralChronoScale plans to raise $153 million by selling 19.1 million shares, plus up to $500 million in preferred stock. Project funding and smaller ownership stakes pull in opposite directions.
12 tech stocks are changing a lot before the market opens on Wednesday.
NeutralChronoScale Holdings shares fell about 9% in Wednesday's pre-market session, but the article reports no company news. The share move alone does not change the outlook for its business.
ChronoScale Holdings Corp shares news about CEO Scott Davis leaving and new directors and officers being chosen.
NeutralCHRN reports a board departure tied to its completed Ekso sale, with a cash payment and vested stock units. The filing does not clearly change the company's outlook.
ChronoScale Holdings Corp says some directors and officers are leaving, and new ones are being chosen.
NeutralChronoScale sold Ekso and announced an expanded AI customer agreement, but gave no sale price or contract terms. A $243,750 severance payment leaves no clear business change.
ChronoScale is growing its AI projects and aims to make $1 billion a year by 2027.
Good for CHRNChronoScale added AI infrastructure contracts tied to a $1 billion yearly revenue pace in 2027 and sold Ekso Bionics to focus on AI, supporting its business outlook.